Adequately 0 10 0 10 O
treated 11 18 11 18 O
basal 19 24 19 24 B-cancer
cell 25 29 25 29 I-cancer
or 30 32 30 32 O
squamous 33 41 33 41 B-cancer
cell 42 46 42 46 I-cancer
skin 47 51 47 51 I-cancer
cancer 52 58 52 58 I-cancer
; 58 59 58 59 O
In 60 62 60 62 B-cancer
situ 63 67 63 67 I-cancer
cervical 68 76 68 76 I-cancer
cancer 77 83 77 83 I-cancer
; 83 84 83 84 O
Adequately 85 95 85 95 O
treated 96 103 96 103 O
Stage 104 109 104 109 B-cancer
I 110 111 110 111 I-cancer
or 112 114 112 114 I-cancer
II 115 117 115 117 I-cancer
cancer 118 124 118 124 I-cancer
from 125 129 125 129 O
which 130 135 130 135 O
the 136 139 136 139 O
patient 140 147 140 147 O
is 148 150 148 150 O
currently 151 160 151 160 O
incomplete 161 171 161 171 O
remission 172 181 172 181 O
or 182 184 182 184 O
other 185 190 185 190 O
cancer 191 197 191 197 O
from 198 202 198 202 O
which 203 208 203 208 O
the 209 212 209 212 O
patient 213 220 213 220 O
has 221 224 221 224 O
been 225 229 225 229 O
disease 230 237 230 237 O
- 237 238 237 238 O
free 238 242 238 242 O
for 243 246 243 246 O
2 247 248 247 248 O
years 249 254 249 254 O

Allergy 0 7 255 262 O
to 8 10 263 265 O
measles 11 18 266 273 B-allergy_name
vaccine 19 26 274 281 I-allergy_name
or 27 29 282 284 O
history 30 37 285 292 O
of 38 40 293 295 O
severe 41 47 296 302 O
reaction 48 56 303 311 O
to 57 59 312 314 O
prior 60 65 315 320 O
measles 66 73 321 328 O
vaccination 74 85 329 340 O

Any 0 3 341 344 O
of 4 6 345 347 O
the 7 10 348 351 O
following 11 20 352 361 O
prior 21 26 362 367 O
therapy 27 34 368 375 O
: 34 35 375 376 O
Chemotherapy 36 48 377 389 B-treatment
≤ 49 50 390 391 O
3 51 52 392 393 B-upper_bound
weeks 53 58 394 399 I-upper_bound
prior 59 64 400 405 I-upper_bound
to 65 67 406 408 O
registration 68 80 409 421 O
. 80 81 421 422 O
Biologic 82 90 423 431 B-treatment
therapy 91 98 432 439 I-treatment
≤ 99 100 440 441 O
4 101 102 442 443 B-upper_bound
weeks 103 108 444 449 I-upper_bound
prior 109 114 450 455 I-upper_bound
to 115 117 456 458 O
registration 118 130 459 471 O
. 130 131 471 472 O
Radiation 132 141 473 482 B-treatment
therapy 142 149 483 490 I-treatment
≤ 150 151 491 492 O
3 152 153 493 494 O
weeks 154 159 495 500 O
prior 160 165 501 506 O
to 166 168 507 509 O
registration 169 181 510 522 O

Diagnosis 0 9 523 532 O
of 10 12 533 535 O
Urothelial 13 23 536 546 B-cancer
carcinoma 24 33 547 556 I-cancer
( 34 35 557 558 I-cancer
UC 35 37 558 560 I-cancer
) 37 38 560 561 I-cancer
of 39 41 562 564 I-cancer
the 42 45 565 568 I-cancer
bladder 46 53 569 576 I-cancer
, 53 54 576 577 O
with 55 59 578 582 O
histologic 60 70 583 593 O
confirmation 71 83 594 606 O
of 84 86 607 609 O
primary 87 94 610 617 O
UC 95 97 618 620 O
pathology 98 107 621 630 O

ECOG 0 4 631 635 B-clinical_variable
Performance 5 16 636 647 I-clinical_variable
Status 17 23 648 654 I-clinical_variable
( 24 25 655 656 I-clinical_variable
PS 25 27 656 658 I-clinical_variable
) 27 28 658 659 I-clinical_variable
0 29 30 660 661 B-lower_bound
or 31 33 662 664 O
1 34 35 665 666 B-upper_bound

History 0 7 667 674 O
of 8 10 675 677 O
or 11 13 678 680 O
concurrent 14 24 681 691 O
non 25 28 692 695 B-cancer
- 28 29 695 696 I-cancer
invasive 29 37 696 704 I-cancer
UC 38 40 705 707 I-cancer
involving 41 50 708 717 O
a 51 52 718 719 O
portion 53 60 720 727 O
of 61 63 728 730 O
urinary 64 71 731 738 O
tract 72 77 739 744 O
outside 78 85 745 752 O
of 86 88 753 755 O
the 89 92 756 759 O
bladder 93 100 760 767 O

History 0 7 768 775 O
of 8 10 776 778 O
organ 11 16 779 784 B-treatment
transplantation 17 32 785 800 I-treatment

Men 0 3 801 804 B-gender
or 4 6 805 807 I-gender
women 7 12 808 813 I-gender
of 13 15 814 816 O
childbearing 16 28 817 829 O
potential 29 38 830 839 O
who 39 42 840 843 O
are 43 46 844 847 O
unwilling 47 56 848 857 B-contraception_consent
to 57 59 858 860 I-contraception_consent
employ 60 66 861 867 I-contraception_consent
adequate 67 75 868 876 I-contraception_consent
contraception 76 89 877 890 I-contraception_consent
during 90 96 891 897 O
treatment 97 106 898 907 B-treatment
and 107 110 908 911 O
8 111 112 912 913 O
weeks 113 118 914 919 O
following 119 128 920 929 O
the 129 132 930 933 O
completion 133 143 934 944 O
of 144 146 945 947 O
study 147 152 948 953 O
drug 153 157 954 958 O
treatment 158 167 959 968 O

Must 0 4 969 973 O
be 5 7 974 976 O
willing 8 15 977 984 B-contraception_consent
to 16 18 985 987 I-contraception_consent
implement 19 28 988 997 I-contraception_consent
contraception 29 42 998 1011 I-contraception_consent
throughout 43 53 1012 1022 O
study 54 59 1023 1028 O
and 60 63 1029 1032 O
for 64 67 1033 1036 O
30 68 70 1037 1039 B-upper_bound
days 71 75 1040 1044 I-upper_bound
following 76 85 1045 1054 O
RC 86 88 1055 1057 O

Nursing 0 7 1058 1065 O
women 8 13 1066 1071 B-gender

Patients 0 8 1072 1080 O
with 9 13 1081 1085 O
any 14 17 1086 1089 O
other 18 23 1090 1095 O
prior 24 29 1096 1101 O
malignancy 30 40 1102 1112 B-cancer
are 41 44 1113 1116 O
not 45 48 1117 1120 O
allowed 49 56 1121 1128 O

Pregnant 0 8 1129 1137 B-pregnancy
women 9 14 1138 1143 B-gender

Prior 0 5 1144 1149 B-treatment
treatment 6 15 1150 1159 I-treatment
with 16 20 1160 1164 O
an 21 23 1165 1167 O
anti 24 28 1168 1172 B-treatment
- 28 29 1172 1173 I-treatment
PD-1 29 33 1173 1177 I-treatment
, 33 34 1177 1178 O
anti 35 39 1179 1183 B-treatment
- 39 40 1183 1184 I-treatment
PD 40 42 1184 1186 I-treatment
- 42 43 1186 1187 I-treatment
L1 43 45 1187 1189 I-treatment
, 45 46 1189 1190 O
anti 47 51 1191 1195 B-treatment
- 51 52 1195 1196 I-treatment
PD 52 54 1196 1198 I-treatment
- 54 55 1198 1199 I-treatment
L2 55 57 1199 1201 I-treatment
, 57 58 1201 1202 O
anti 59 63 1203 1207 B-treatment
- 63 64 1207 1208 I-treatment
CTLA-4 64 70 1208 1214 I-treatment
antibody 71 79 1215 1223 O
, 79 80 1223 1224 O
or 81 83 1225 1227 O
any 84 87 1228 1231 O
other 88 93 1232 1237 O
antibody 94 102 1238 1246 O
or 103 105 1247 1249 O
drug 106 110 1250 1254 O
specifically 111 123 1255 1267 O
targeting 124 133 1268 1277 O
T 134 135 1278 1279 O
- 135 136 1279 1280 O
cell 136 140 1280 1284 O
co 141 143 1285 1287 O
- 143 144 1287 1288 O
stimulation 144 155 1288 1299 O
or 156 158 1300 1302 O
immune 159 165 1303 1309 O
checkpoint 166 176 1310 1320 O
pathways 177 185 1321 1329 O

Variant 0 7 1330 1337 O
UC 8 10 1338 1340 O
pathology 11 20 1341 1350 O
including 21 30 1351 1360 O
but 31 34 1361 1364 O
not 35 38 1365 1368 O
limited 39 46 1369 1376 O
to 47 49 1377 1379 O
micropapillary 50 64 1380 1394 B-cancer
, 64 65 1394 1395 O
signet 66 72 1396 1402 O
ring 73 77 1403 1407 O
, 77 78 1407 1408 O
sarcomatoid 78 89 1408 1419 B-cancer
, 89 90 1419 1420 O
and 91 94 1421 1424 O
clear 95 100 1425 1430 B-cancer
cell 101 105 1431 1435 I-cancer
variants 106 114 1436 1444 I-cancer

indication 0 10 1445 1455 O
for 11 14 1456 1459 O
Radical 15 22 1460 1467 B-treatment
cystectomy 23 33 1468 1478 I-treatment
( 34 35 1479 1480 I-treatment
RC 35 37 1480 1482 I-treatment
) 37 38 1482 1483 I-treatment

